CHIP, mCAs, and Cancer Risk: What We’re Learning

https://is1-ssl.mzstatic.com/image/thumb/Podcasts116/v4/9a/ee/33/9aee3362-8129-8fe2-daf8-daa3debb0eed/mza_5949395731523819500.png/600x600bb.jpg

CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society

ACS Journal Cancer

18 episodes

1 week ago

Introducing CancerSpeak, the official podcast of Cancer, a journal of the American Cancer Society. CancerSpeak is dedicated to bringing the best of science to the broadest audiences, offering the latest research, real-life stories, and expert perspectives from the field of oncology.

All content for CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society is the property of ACS Journal Cancer and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness,

Science

CHIP, mCAs, and Cancer Risk: What We’re Learning

CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society

21 minutes 19 seconds

12 months ago

CHIP, mCAs, and Cancer Risk: What We’re Learning

CANCER Section Editor and Host Dr. Courtney DiNardo welcomes Dr. Pinkal Desai, Dr. Koichi Takahashi, and Ms. Nehali Shah to discuss new research on the impact of clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal alterations (mCAs) on the risk and mortality of solid tumors like breast, lung, and colorectal cancer. Dr. Desai highlights findings from her recent study published in CANCER, while Dr. Takahashi and Ms. Shah share perspectives from their accompanying editorial. The episode explores the potential impact of these findings on clinical care and future research directions. Read Dr. Desai’s article: https://bit.ly/CHIPandmCAsonSolidTumorRisk Read the editorial by Dr. Takahashi and Ms. Shah: https://bit.ly/CHIPandmCAsEditorial Music by Ivymusic, obtained from Pixabay.